These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 11002539)

  • 1. [Digestive implications of graft versus host disease].
    Carreras E
    Gastroenterol Hepatol; 2000; 23(7):354-60. PubMed ID: 11002539
    [No Abstract]   [Full Text] [Related]  

  • 2. The role of innate immunity in graft-versus-host disease and complications following allogeneic stem cell transplant.
    Holler E
    Biol Blood Marrow Transplant; 2009 Jan; 15(1 Suppl):59-61. PubMed ID: 19147080
    [No Abstract]   [Full Text] [Related]  

  • 3. Alveolar hemorrhage and acute graft-versus-host disease.
    Ratajczak P; Desveaux A; Socié G; Janin A
    Biol Blood Marrow Transplant; 2007 Oct; 13(10):1244-5. PubMed ID: 17889362
    [No Abstract]   [Full Text] [Related]  

  • 4. Anesthesia and graft-vs-host disease after hematopoietic stem cell transplantation.
    Thiruvenkatarajan V; Rebecca J
    Paediatr Anaesth; 2007 Jan; 17(1):7-15. PubMed ID: 17184425
    [No Abstract]   [Full Text] [Related]  

  • 5. Graft vs. host disease: pathology, prophylaxis and therapy: GVHD overview.
    Weisdorf D
    Best Pract Res Clin Haematol; 2008 Jun; 21(2):99-100. PubMed ID: 18503978
    [No Abstract]   [Full Text] [Related]  

  • 6. Graft-versus-host disease in the 21st century: new perspectives on an old problem.
    Ferrara JL; Levine JE
    Semin Hematol; 2006 Jan; 43(1):1-2. PubMed ID: 16412783
    [No Abstract]   [Full Text] [Related]  

  • 7. Acute graft-versus-host disease in children.
    Jacobsohn DA
    Bone Marrow Transplant; 2008 Jan; 41(2):215-21. PubMed ID: 17934526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Usefulness of magnifying endoscopic evaluation of the terminal ileum for a patient with graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
    Onozawa M; Yonezumi M; Kawarazaki M; Izumiyama K; Chiba K; Kondo T; Ota S; Kobayashi S; Kato M; Hashino S; Tanaka J; Imamura M; Asaka M
    Ann Hematol; 2005 Feb; 84(2):106-9. PubMed ID: 15300409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimizing care for GI disorders in children after hematopoietic stem cell transplantation.
    Berquist W; Dvorak CC
    Gastrointest Endosc; 2006 Sep; 64(3):386-8. PubMed ID: 16923487
    [No Abstract]   [Full Text] [Related]  

  • 10. Deep lamellar keratoplasty for corneal perforation due to chronic graft-versus-host disease following allogeneic hematopoietic stem-cell transplantation.
    Yuta K; Kami M; Matsumoto Y; Murashige N; Suzuki S
    Haematologica; 2005 Mar; 90(3):ECR15. PubMed ID: 15753056
    [No Abstract]   [Full Text] [Related]  

  • 11. Acquired ichthyosis as a manifestation of acute cutaneous graft-versus-host disease.
    Huang J; Pol-Rodriguez M; Silvers D; Garzon MC
    Pediatr Dermatol; 2007; 24(1):49-52. PubMed ID: 17300650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathophysiology of graft-versus-host disease.
    Ferrara JL; Reddy P
    Semin Hematol; 2006 Jan; 43(1):3-10. PubMed ID: 16412784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gastrointestinal toxicity from the preparative regimen is associated with an increased risk of graft-versus-host disease.
    Goldberg J; Jacobsohn DA; Zahurak ML; Vogelsang GB
    Biol Blood Marrow Transplant; 2005 Feb; 11(2):101-7. PubMed ID: 15682070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Allogeneic hematopoietic stem-cell transplantation for hematological malignancies].
    Michallet M; Dhedin N; Michallet AS
    Bull Cancer; 2001 Sep; 88(9):908-26. PubMed ID: 11604365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. B-cell involvement in chronic graft-versus-host disease.
    Kapur R; Ebeling S; Hagenbeek A
    Haematologica; 2008 Nov; 93(11):1702-11. PubMed ID: 18728020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brazilian Nutritional Consensus in Hematopoietic Stem Cell Transplantation: Graft- versus -host disease.
    Pereira AZ; Vigorito AC; Almeida AM; Candolo AA; Silva ACL; Brandão-Anjos AEP; Sá BL; Souza CLS; Castro Junior CG; Oliveira JSR; Barban JB; Mancilha EMB; Todaro J; Lopes LP; Macedo MCMA; Rodrigues M; Ribeiro PC; Silva RLD; Roberto TS; Rodrigues TCR; Colturato VAR; Paton EJA; Barros GMN; Almeida RDS; Moreira MCR; Flowers ME
    Einstein (Sao Paulo); 2020; 18():eAE4799. PubMed ID: 32215466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cutaneous manifestations of chronic graft-versus-host disease.
    Hymes SR; Turner ML; Champlin RE; Couriel DR
    Biol Blood Marrow Transplant; 2006 Nov; 12(11):1101-13. PubMed ID: 17085303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytomegalovirus infection and chronic graft-versus-host disease are significant predictors of renal failure after allogeneic hematopoietic stem cell transplantation.
    Deconinck E; Kribs M; Rebibou JM; Bulabois CE; Ducloux D; Cahn JY
    Haematologica; 2005 Apr; 90(4):569-70. PubMed ID: 15820963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Central nervous system graft-versus-host disease post allogeneic stem cell transplant.
    Shortt J; Hutton E; Faragher M; Spencer A
    Br J Haematol; 2006 Jan; 132(2):245-7. PubMed ID: 16398660
    [No Abstract]   [Full Text] [Related]  

  • 20. Crypt loss is a marker of clinical severity of acute gastrointestinal graft-versus-host disease.
    Melson J; Jakate S; Fung H; Arai S; Keshavarzian A
    Am J Hematol; 2007 Oct; 82(10):881-6. PubMed ID: 17570511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.